X4 Pharmaceuticals
XFOR
$1.01
Share price
3.49%
Change (1 day)
-54.50%
Change (1 year)
Categories
X4 Pharmaceuticals (XFOR) - P/B ratio
P/B ratio as of June 2024 : 158
According to X4 Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 158.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
X4 Pharmaceuticals - P/B ratio (from 2017 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.75 | 68.44% |
| 2022-12-31 | 1.63 | 62.97% |
| 2021-12-31 | 1.00 | -30.48% |
| 2020-12-31 | 1.44 | 7.71% |
| 2019-12-31 | 1.34 | -14.67% |
| 2018-12-31 | 1.57 | -47.42% |
| 2017-12-31 | 2.98 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -98.84% | 🇺🇸 USA |